To The Moon

Muthu boy’s Prata Stall Has No Michelin Star Every single Sunday, like clockwork, you show up at my stall. You order your usual—two crispy egg pratas drowned in extra fish curry—and then, with a mouthful of dough, you look me dead in the eye and ask: "Boss, why your stall still no Michelin star?" Boss , look around. Charcoal fire, aluminium table, tissue paper for napkin. Michelin people never come here. Maybe they scared of the chilli. But let me tell you something funny. That little red star that can make a chef cry, kill himself, or become rich overnight… it started from a tyre company that couldn’t even give away their free book. Sit down. Eat your prata. I tell you the whole story. Chapter 1: The Chef Who Never Woke Up24 February 2003.  Small town of Saulieu, France. Three-M

📊 Market Recap As of the close on October 16, 2026 (America/New_York), 'GOOGL' settled at $340.59, down -2.47% (-$8.63). The stock is now approximately 16.6% below its 52-week high of $408.61, with after-hours trading slipping further to $340.69. The pre-market quote on October 16 was $348.50, indicating sustained selling pressure into the close. The sharp pullback from the $350.66 intraday high pushed the stock toward its primary technical support near $339. The decline was accompanied by a volume ratio of 1.30, suggesting above-average turnover as holders locked in profits following the prior multi-week rally. 🚀 Key Drivers Valuation Reset Pressures: Forward P/E has compressed to 16.96, well below its historical average of 22.37, signaling that the market is pricing in slower near-term e

📊 Market Recap As of the October 17, 2026 U.S. session, 'AXTI' closed at $51.47, down -11.12% with an intraday amplitude of 10.38%. The stock is now trading roughly 64% below its 52-week high of $143.16, though still far above its 52-week low of $4.35. A sharp post-hours print near $52.00 and a weak pre-market quote of $56.27 suggest selling pressure extended beyond regular trading. 🚀 Key Drivers Sector-wide semiconductor slump: Semiconductor equipment names broadly weakened, with Applied Materials, Lam Research, KLA, and Teradyne all closing lower, dragging 'AXTI' down in a risk-off tape for the group. Elevated short interest: Short volume ratio climbed from 11.11% on October 7 to 16.88% by October 14, indicating increased bearish positioning into the decline. High turnover and volatility

📊 Market Recap As of the latest New York session, 'META' closed at $709.325, down -3.72% from the prior close of $736.72. The stock now sits roughly 9.0% below its 52-week high of $779.82, with intraday trading ranging from $702.71 to $738.49. After-hours quotes showed further pressure near $709.95, suggesting near-term sentiment remains cautious despite fresh AI-related headlines. 🚀 Key Drivers Open AI Model Launch: Meta reportedly released a new open AI model and partnered with Apple to run it on Mac, but the positive catalyst failed to sustain buying momentum into the close. Profit-Taking After Rally: With the stock previously trading near $750 resistance, a -3.72% pullback reflects broad-based de-risking rather than a fundamental shift. Macro/AI Sentiment Cooling: Elevated short-volume

📊 Market Recap As of the October 17 close, 'NVDA' finished at $214.13, down -1.43% (-$3.10). The stock remains in a short-term corrective phase, trading roughly 12% below its 52-week high of $243.37, while holding well above the 52-week low of $164.27. Pre-market strength near $216.52 faded into the regular session, leaving price near the low end of the day's $213.32-$218.68 range and signaling continued distribution pressure. 🚀 Key Drivers AI Chip Design Partnership: 'Nvidia' and ChipAgents launched a joint Build-A-Chip-Bench benchmark to evaluate autonomous AI reasoning, timing, power, area, and physical verification across the complete chip design flow, reinforcing NVDA's AI infrastructure leadership narrative. Elevated Short-Selling Pressure: Short volume jumped to 11.14 million shares

📊 Market Recap Moderna, Inc. ('MRNA') closed at $218.01 on October 17, 2026, down -7.82% from the previous close of $236.50. The stock traded in a wide range of $208.92 to $237.96, with turnover rate reaching 5.34%. Despite the sharp pullback, 'MRNA' remains only about 10% below its 52-week high of $242.29, reflecting the intense tug-of-war between cancer vaccine optimism and profit-taking pressure. 🚀 Key Drivers Cancer Vaccine Narrative: Positive Phase III results for Moderna's mRNA cancer vaccine combined with Keytruda have reshaped its oncology pipeline story, sending the stock up more than 650% year-to-date. NIH Partnership Catalyst: Reports that the National Institutes of Health is part of a public-private partnership to accelerate cancer vaccine development boosted sentiment across t

① What Happened Today AI computing power is being questioned. Earnings season will decide if the rally can continue. AI supply chain under pressure: The world's top 20 tech stocks lost over $1 trillion in market value this week. The market worries whether huge AI investments will pay off. Nvidia's Jensen Huang pushed back on the idea that the market relies too much on a few AI companies. He said compute demand also comes from businesses, cloud services, and traditional computing. Short-term focus: can Nvidia keep confidence in the AI supply chain steady? Tesla up over 3% premarket: The "flying supercar" Roadster was shown. The new car uses SpaceX rocket propulsion tech, showed mid-air flips, and is planned for 2028 mass production. The news boosts excitement about Tesla's tech innovation.

I see this as a valuation reset rather than the end of the AI story. AI demand remains strong, but investors are becoming more selective about capital spending, financing costs and cash flow. Growth alone is no longer enough when valuations are stretched. Personally, I would consider healthcare and consumer staples for diversification, as their earnings tend to be more resilient. However, I would not chase defensive stocks simply because they are outperforming. Valuation and cash flow still matter, especially in a higher-for-longer interest rate environment. For my portfolio, I prefer to stay disciplined rather than react to short-term rotations. I will monitor Treasury yields, earnings and technical levels while continuing to accumulate quality companies patiently on pullbacks. Consisten

Disclaimer: Nothing I say or post should be considered financial advice. Please do your own due diligence before making any investment decisions.‌ $Technology Select Sector SPDR Fund(XLK)$ $Roundhill Memory ETF(DRAM)$ $VanEck Semiconductor ETF(SMH)$ $Utilities Select Sector SPDR Fund(XLU)$ $Communication Services Select Sector SPDR Fund(XLC)$ So the real bloothbath finally started today, with 80 billion dollars wiped out from the AI sector in a single day. The sector did bounce back a little towards end of trading day, but could this be a start of a bearish momentum carrying into en

I would focus on HBM rather than chase a broad memory rebound. SK Hynix still has the strongest technology and market position in HBM, while Micron may offer the more interesting catch-up story if it continues gaining HBM share and securing long-term AI orders. Micron has also said demand should exceed supply through 2027 and 2028, which suggests CXMT’s expansion may not immediately create an industry-wide glut. CXMT is a genuine longer-term threat, especially in conventional server DRAM, but advanced HBM remains much harder to replicate at scale. SanDisk and WDC could recover with strong data-centre storage demand, but that is a somewhat different AI infrastructure thesis and I would rank it behind HBM for now. My preference: SK Hynix technology lead > Micron HBM share gains > SanDi

Mkt reaction to TSLA's Thursday event, where the next-generation Roadster attached with SpaceX cold-gas thrusters & fan suction—was a mix of awe over the technical spectacle and widespread skepticism regarding its commercial viability. Still it exacted a reaction. So far, TSLA is poised to open higher on Friday (+3.98%).  Is redemption on the card? Whatever the case might be, stay cool and observe first.

Honestly, I feel like I've unlocked the ultimate achievement of experiencing all 8 of these painful trading moments firsthand. From watching a stock rocket right after I sold to holding a bag after buying the top, the market always finds a way to humble us. The one that definitely hurt the most is #5: Big gains on paper… but now it’s red. Watching a position sit comfortably at +50% and refusing to lock in profits, only to ride it all the way down into a 10% loss, is a unique kind of emotional damage. Another classic facepalm moment is #7: Picked the winner... but bought too little. I remember nailing the research and picking a massive winner, but only putting in a tiny allocation, watching it surge +100% while my heavy-conviction positions stayed completely flat!

Hi Tigers! 🐯 Let’s look at four names on the radar today. Some are holding constructive setups, while others need to reclaim key levels before the bullish case strengthens. 📈 $Meta Platforms, Inc.(META)$ — The breakout remains solid above the 20DMA. A break below that average could open the way to the lower Bollinger Band, but there’s no reason to anticipate that move before the blue line breaks. For this week, keep 725.9 on your radar. 🎯 $Netflix(NFLX)$ — Yesterday’s analysis highlighted a constructive setup, and the follow-through delivered. The price action played out as expected. 💪 $Qualcomm(QCOM)$ — Wednesday’s resilience hinted at a bounce, and Thursday’s r